Skip to content

Role of Functional Translation After Immersive Virtual Reality Exposure in Persons With Stroke

Role of Functional Translation After Immersive Virtual Reality Exposure in Persons With Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04360460
Enrollment
10
Registered
2020-04-24
Start date
2020-12-03
Completion date
2022-08-18
Last updated
2023-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiparesis as Late Effect of Cerebrovascular Disease

Brief summary

This is a single-blinded randomized control trial aiming to explore the use of immersive virtual reality (VR) training in conjunction with real-life tasks therapy in 75 first time stroke patients with upper limb weakness.

Detailed description

Patients will be randomized to a control or experimental group. The experimental group will receive immersive VR training followed by the translation of related tasks in a real life environment. The control group will perform the same tasks in a real life environment but will receive immersive VR exposure to a non-related task.

Interventions

OTHERImmersive virtual reality + related functional translation into real-life

The experimental group will perform tasks in an immersive virtual reality setting designed to encourage functional task performance for 30 minutes. The patient will then be brought to a real-life setting and evaluated on similar task performances for an additional 30 minutes for a total of 60 minutes per day, 3 times a week for 2 weeks.

OTHERImmersive virtual reality + non-related translation into real-life

The control group will also be asked to perform tasks in an immersive VR setting for 30 minutes, however tasks will be unrelated to the tasks performed in the real-life setting in the following 30 minutes. The control group will also receive 60 minutes of therapy a day, 3 times a week, for 2 weeks.

Sponsors

Loma Linda University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. 18-90 years old 2. Hospitalized at Loma Linda East Campus Rehabilitation Hospital 3. First time stroke patient 4. Upper limb hemiparesis 5. English-speaking 6. Manual muscle testing of at least 2/5 in 3 or more muscle groups in affected upper limb

Exclusion criteria

1. Active neck pain, headaches, or vertigo limiting ability to tolerate Virtual Reality Head Mounted Device 2. Patients with hemicraniectomy 3. Current uncontrolled seizures 4. Active infections requiring contact precautions 5. Cognitively unable to participate 6. Vision loss limiting ability to participate with VR therapy

Design outcomes

Primary

MeasureTime frameDescription
Motor Activity LogChange in score (between baseline and time of discharge from rehabilitation hospital, about 2 weeks)ADL Self-Reported Questionnaire Amount Scale (0-5) 0 = Did not use my weaker arm (not used) 5 = Used my weaker arm as often as before the stroke (same as pre-stroke). How well scale (0-5) 0 - My weaker arm was not used at all for that activity (not used). 5 - The ability to use my weaker arm for that activity was as good as before the stroke (normal).

Secondary

MeasureTime frameDescription
Modified Barthel's IndexChange in score (between baseline and time of discharge from rehabilitation hospital, about 2 weeks)Quality of Life Self-Reported Questionnaire 80-100 Independent 60-79 Minimally dependent 40-59 Partially dependent 20-39 Very dependent \<20 Totally dependent
Fugl-Meyer Upper Extremity AssessmentChange in score (between baseline and time of discharge from rehabilitation hospital, about 2 weeks)Post-stroke upper extremity assessment Very severe = 0-35 Severe = 36-55 Moderate. = 56-79 Slight = \>79
Montreal Cognitive AssessmentChange in score (between baseline and time of discharge from rehabilitation hospital, about 2 weeks)Cognitive Assessment No cognitive impairment: MoCA ≥ 25 Mild cognitive impairment: MoCA 20-24 Severe cognitive impairment: MoCA \< 20
Functional Independence Measurement ScoreChange in score (between baseline and time of discharge from rehabilitation hospital, about 2 weeks)Functional evaluation 7 - complete independence 6 - modified indepdendence 5 - supervision/Setup 4 - minimal contact assistance 3 - moderate assistance 2 - maximal assistance 1 - total assistance 0 - activity does not occur

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026